Investors

Growing Shareholder Value

Filter Releases

Abiomed Introduces 3rd Generation Impella CP® Heart Pumps at SCAI 2017

May 09, 2017
Read More

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

May 04, 2017
Read More

Abiomed Announces Q4 FY 2017 Revenue of $124.7 Million, Up 33% Over Prior Year and Total Year Revenue of $445.3 Million, Up 35% Over Prior Year

May 04, 2017
Read More

Abiomed Fourth Quarter Fiscal 2017 Earnings and Conference Call Notification

April 13, 2017
Read More

Abiomed Marks Grand Opening of Newly-Expanded Headquarters in Danvers, Massachusetts

March 30, 2017
Read More

First-Ever Presentation on Abiomed's Impella® Quality (IQ) Assurance Program and Importance of Treatment Protocols to Improve Patient Survival and Heart Recovery at the 2017 American College of Cardiology Scientific Session

March 19, 2017
Read More

Abiomed's Impella® Technology Showcased at 2017 American College of Cardiology Scientific Session With More Than 10 Presentations

March 16, 2017
Read More

New Study Finds Abiomed Impella® Heart Pump Reduces Injury to Kidneys During High-Risk Percutaneous Coronary Intervention

March 09, 2017
Read More

Abiomed Surpasses 50,000 Impella® Patients Treated in the United States

February 23, 2017
Read More

Abiomed Celebrates 2017 American Heart Month

February 21, 2017
Read More

Abiomed Announces Q3 FY 2017 Revenue of $114.7 Million, Up 34% Over Prior Year

January 26, 2017
Read More

Abiomed Announces Preliminary Q3 FY 2017 Revenue of $114.7 Million, Up 34% Over Prior Year

January 09, 2017
Read More

Abiomed Third Quarter Fiscal 2017 Earnings and Conference Call Notification

January 05, 2017
Read More

Abiomed to Present at the 35th Annual J.P. Morgan Healthcare Conference

December 27, 2016
Read More

Abiomed Impella CP Receives Expanded FDA Approval for High-Risk Percutaneous Coronary Intervention (PCI) Procedures

December 07, 2016
Read More

Abiomed Launches Impella Quality (IQ) Assurance Program and Shares Insight From Largest Database of Real-World Evidence of High-Risk PCI and Cardiogenic Shock Patients

October 31, 2016
Read More

Abiomed Announces Q2 FY 2017 Revenue of $103 Million, Up 35% Over Prior Year

October 27, 2016
Read More

Abiomed Receives FDA IDE Approval for Initiation of Door to Unloading (DTU) Prospective Feasibility Study

October 27, 2016
Read More

Abiomed's Impella Technology Showcased at TCT 2016 With More Than 25 Presentations During Scientific Sessions

October 25, 2016
Read More

Abiomed Second Quarter Fiscal 2017 Earnings and Conference Call Notification

October 06, 2016
Read More

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

September 27, 2016
Read More

Abiomed Announces Q1 FY 2017 Revenue of $103.0 Million, Up 40% Over Prior Year

July 28, 2016
Read More

Abiomed First Quarter Fiscal 2017 Earnings and Conference Call Notification

July 07, 2016
Read More

Abiomed to Present at the William Blair 2016 Growth Stock Conference

June 07, 2016
Read More

Abiomed to Present at the Jefferies 2016 Healthcare Conference

June 03, 2016
Read More

Abiomed Announces Q4 FY 2016 Revenue of $94.0 Million, Up 39% Over Prior Year

May 03, 2016
Read More

Abiomed Fourth Quarter Fiscal 2016 Earnings and Conference Call Notification

April 12, 2016
Read More

Abiomed Impella Devices Support 37,673 Patients, Enough to Fill Historic Fenway Park

April 12, 2016
Read More

Abiomed Impella® Therapy Receives FDA Approval for Cardiogenic Shock After Heart Attack or Heart Surgery

April 07, 2016
Read More

Abiomed Announces Appointments of Jeannine Rivet and Christopher Van Gorder to Board of Directors

February 08, 2016
Read More

Abiomed Announces Q3 FY 2016 Revenue of $85.8 Million, Up 38% Over Prior Year

February 04, 2016
Read More

Abiomed Third Quarter Fiscal 2016 Earnings and Conference Call Notification

January 26, 2016
Read More

Abiomed Announces Preliminary Q3 FY 2016 Revenue of $85.8 Million, Up 38% Over Prior Year

January 11, 2016
Read More

Abiomed to Present at the 34th Annual J.P. Morgan Healthcare Conference

December 29, 2015
Read More

Abiomed Announces Q2 FY 2016 Revenue of $76.4 Million, Up 47% Over Prior Year

October 29, 2015
Read More

Abiomed's Impella(R) Technology Showcased at TCT 2015 With Over 25 Presentations in the Scientific Sessions

October 08, 2015
Read More

Abiomed Second Quarter Fiscal 2016 Earnings and Conference Call Notification

October 08, 2015
Read More

Abiomed to Appoint Seth Bilazarian, M.D., New Vice President of Interventional Cardiology Programs

October 08, 2015
Read More

Abiomed to Present at the Morgan Stanley Global Healthcare Conference

September 10, 2015
Read More

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0/LD Pre-Market Approval Supplements

August 17, 2015
Read More

Abiomed Announces Corporate Partnership With Fenway Park; Brings Impella Mobile Learning Lab to Historic Stadium

August 11, 2015
Read More

Abiomed Outlines Long-Term Growth Strategy and Unveils Future Products at Annual Investor Conference

August 11, 2015
Read More

Abiomed to Hold Investor Day in Boston on August 11

August 05, 2015
Read More

Abiomed Announces Q1 FY 2016 Revenue of $73.4 Million, Up 50% Over Prior Year

August 04, 2015
Read More

Abiomed First Quarter Fiscal 2016 Earnings and Conference Call Notification

July 14, 2015
Read More

United States Department of Justice Closes Investigation Into Abiomed's Impella 2.5

June 29, 2015
Read More

Abiomed to Present at the William Blair Growth Stock Conference

June 04, 2015
Read More

Abiomed to Appoint New Chief Financial Officer Michael Tomsicek

June 01, 2015
Read More

Abiomed to Present at the Jefferies 2015 Global Healthcare Conference

June 01, 2015
Read More

Abiomed Announces Record Revenue of $67.6 Million, Up 34% and U.S. Patient Growth Up 42% in Fiscal Fourth Quarter 2015

May 05, 2015
Read More

Abiomed to Present at the Deutsche Bank 40th Annual Health Care Conference

April 30, 2015
Read More

Abiomed Fourth Quarter Fiscal 2015 Earnings and Conference Call Notification

April 21, 2015
Read More

Abiomed Impella 2.5 Receives FDA Approval for Elective and Urgent High Risk Percutaneous Coronary Intervention (PCI) Procedures

March 23, 2015
Read More

Abiomed to Present at the Cowen and Company 35th Annual Health Care Conference

February 25, 2015
Read More

Abiomed to Present at the 2015 Leerink Global Healthcare Conference

February 04, 2015
Read More

Abiomed Receives FDA HDE Approval for the Impella RP

January 27, 2015
Read More

Abiomed Announces Third Quarter Fiscal 2015 Record Revenue of $62.0 Million, up 34% Over the Prior Year

January 27, 2015
Read More

Abiomed Reschedules Third Quarter Fiscal 2015 Earnings Release and Conference Call Due to Northeast Winter Storm

January 26, 2015
Read More

Abiomed Third Quarter Fiscal 2015 Earnings and Conference Call Notification

January 06, 2015
Read More

Abiomed to Present at the Piper Jaffray 26th Annual Healthcare Conference

November 26, 2014
Read More

Abiomed and Area Colleges to Host Life Sciences Career Seminars for Growing Number of Student Veterans

November 20, 2014
Read More

Abiomed to Present at the Jefferies 2014 Global Healthcare Conference

November 17, 2014
Read More

Abiomed Announces Second Quarter Fiscal 2015 Revenue of $51.9 Million, Up 17% Over Prior Year

October 30, 2014
Read More

Abiomed Second Quarter Fiscal 2015 Earnings and Conference Call Notification

October 09, 2014
Read More

Abiomed Appoints Ingrid Goldberg as Director of Investor Relations

September 18, 2014
Read More

Clinical Trial Results for Impella RP Right Ventricular Heart Failure Trial, RECOVER RIGHT, Released at TCT 2014

September 16, 2014
Read More

Data From RECOVER RIGHT Impella RP Trial to be Announced at TCT 2014

September 10, 2014
Read More

Abiomed to Present at the Morgan Stanley Global Healthcare Conference 2014

September 03, 2014
Read More

Abiomed Announces First Quarter Fiscal 2015 Revenue of $48.8 Million, Up 14% Over Prior Year

July 31, 2014
Read More

Abiomed Announces Acquisition of ECP to Broaden and Strengthen Existing Intellectual Property and Product Platform

July 01, 2014
Read More

Abiomed, Salem State University and North Shore Community College Host First-Ever Life Sciences Career Seminar for Veterans

June 04, 2014
Read More

Abiomed to Present at the William Blair Growth Stock Conference

June 04, 2014
Read More

Abiomed Surpasses 20,000 Impella Patients in the United States

June 03, 2014
Read More

Abiomed to Present at the Jefferies 2014 Global Healthcare Conference

May 27, 2014
Read More

Abiomed Receives Continuous Access Protocol (CAP) for RECOVER RIGHT Impella RP Study

May 21, 2014
Read More

Abiomed's Impella(R) Technology Showcased at EuroPCR 2014

May 19, 2014
Read More

Abiomed Announces Fourth Quarter Fiscal 2014 Revenue of $50.4 Million, Up 15%

May 01, 2014
Read More

Abiomed Acquires Exclusive License for Opsens' Optical Sensor Technology

April 15, 2014
Read More

Abiomed Fourth Quarter Fiscal 2014 Earnings and Conference Call Notification

April 10, 2014
Read More

Abiomed Receives CE Mark for Impella RP

April 08, 2014
Read More

Abiomed's Impella(R) Technology Showcased at ACC 2014 Scientific Sessions

March 27, 2014
Read More

Impella Maintains Existing Diagnosis Related Groups (DRGs) Assignment With Updated ICD-10 Coding Issued by the Centers for Medicare & Medicaid Services (CMS)

March 21, 2014
Read More

Abiomed Completes Patient Enrollment in RECOVER RIGHT Impella Study

March 20, 2014
Read More

Medical Technology Veterans Program is renamed the MedTech and BioTech Veterans Program (MVP) and Expands Nationwide

February 05, 2014
Read More

Abiomed to Present at the Leerink Global Healthcare Conference 2014

February 05, 2014
Read More

Abiomed Announces Third Quarter Fiscal 2014 Record Revenue of $46.2 Million, Up 21% Over the Prior Year

January 30, 2014
Read More

Abiomed Third Quarter Fiscal 2014 Earnings and Conference Call Notification

January 09, 2014
Read More

Abiomed to Present at the 25th Annual Piper Jaffray Healthcare Conference

November 26, 2013
Read More

Abiomed to Present at the 2013 Credit Suisse Healthcare Conference

November 07, 2013
Read More

Abiomed Announces Second Quarter Fiscal 2014 Revenue of $44.3 Million, Up 19% Over Prior Year, Driven by Record Impella Utilization

November 06, 2013
Read More

Abiomed to Present at the Stephens Fall Investment Conference

November 05, 2013
Read More

Abiomed's Impella(R) Technology Showcased at TCT 2013 With Over 25 Accepted Presentations in the Scientific Sessions

October 23, 2013
Read More

Abiomed Second Quarter Fiscal 2014 Earnings and Conference Call Notification

October 16, 2013
Read More

Abiomed Provides Multi-Year Grant to Boston Children's Hospital Heart Center

October 01, 2013
Read More

Abiomed to Present at the 4th Annual Credit Suisse Small & Mid Cap Conference

September 11, 2013
Read More

Abiomed to Present at Morgan Stanley Global Healthcare Conference

September 03, 2013
Read More

Abiomed Awarded Federal Contract to Provide Impella Platform to Veterans

August 26, 2013
Read More

Abiomed Surpasses 15,000 Impella Patients in the United States

August 02, 2013
Read More

Abiomed Announces First Quarter Fiscal 2014 Revenue of $42.7 Million, Up 10% Over Prior Year

August 01, 2013
Read More

Abiomed First Quarter Fiscal 2014 Earnings and Conference Call Notification

July 11, 2013
Read More

Abiomed to Present at Goldman Sachs 34th Annual Global Healthcare Conference

June 06, 2013
Read More

Abiomed to Present at William Blair 33rd Annual Growth Stock Conference

June 05, 2013
Read More

Abiomed Receives Reimbursement Approval for Impella in The Netherlands

May 28, 2013
Read More

Abiomed to Present at Deutsche Bank 38th Annual Health Care Conference

May 22, 2013
Read More

Abiomed to Present at UBS Global Health Care Conference

May 17, 2013
Read More

Abiomed to Present at Bank of America Merrill Lynch 2013 Health Care Conference

May 08, 2013
Read More

Abiomed to Present at Bank of America Merrill Lynch 2013 Smid Cap Conference

May 03, 2013
Read More

Abiomed Announces Fourth Quarter GAAP EPS of $0.09 on Record Revenue and Patients Supported

May 02, 2013
Read More

Abiomed Announces Publication of Protect II Cost Effectiveness Study in American Health & Drug Benefits Journal

May 01, 2013
Read More

Abiomed Announces Preliminary Fourth Quarter Revenue of $43.7 Million, Driven by Record Number of Patients Supported

April 17, 2013
Read More

Abiomed Announces First Impella RP Patient Enrolled in Recover Right Study

April 01, 2013
Read More

Abiomed's Impella(R) Technology Showcased at ACC 2013

March 07, 2013
Read More

Abiomed to Present at Barclays Global Healthcare Conference

March 07, 2013
Read More

Abiomed Announces Several Reimbursement Milestones

March 04, 2013
Read More

Abiomed to Present at Cowen and Company 33rd Annual Health Care Conference

February 27, 2013
Read More

Abiomed Receives Close-Out Letter From Food and Drug Administration

February 20, 2013
Read More

Abiomed to Present at Leerink Swann Global Healthcare Conference 2013

February 07, 2013
Read More

Abiomed Announces Revenue of $38.3 Million, Up 19% and Record Impella Patient Usage, Up 26%

February 06, 2013
Read More

Abiomed Third Quarter Fiscal 2013 Earnings and Conference Call Notification

January 17, 2013
Read More

FDA 515i Reclassification Panel Recommends Class III Status for Temporary Ventricular Support Devices in the Non-Roller Type Cardiopulmonary Bypass Blood Pumps Category

December 06, 2012
Read More

Abiomed to Present at 24th Annual Piper Jaffray Healthcare Conference

November 21, 2012
Read More

Abiomed Believes Class Action Lawsuit is Without Merit and Intends to Defend Vigorously

November 16, 2012
Read More

Abiomed Announces Stock Repurchase Program

November 13, 2012
Read More

AdvaMed Launches MVP Mentoring Portal for Veterans

November 12, 2012
Read More

Abiomed Receives FDA IDE Approval for Use of New Impella RP in Pivotal Clinical Study

November 12, 2012
Read More

Abiomed to Present at 2012 Credit Suisse Annual Health Care Conference

November 09, 2012
Read More

Abiomed to Present at Lazard Capital Markets 9th Annual Healthcare Conference

November 07, 2012
Read More

Centers for Medicare and Medicaid Services Announces New Dedicated Category I CPT Physician Payment Rates for Impella

November 02, 2012
Read More

Abiomed Announces Revenue of $37.4 Million, Up 27% and Worldwide Impella(R) Revenue Growth of 32%

November 01, 2012
Read More

Abiomed to Present at 7th Annual Morningstar 2012 Management Behind the Moat Conference

October 30, 2012
Read More

Abiomed Reschedules Its Second Quarter Fiscal 2013 Earnings Release and Conference Call Due to Hurricane Sandy

October 30, 2012
Read More

Abiomed Announces Clinical Progress on Symphony Program, Including Second Successful Implant in Canada

October 23, 2012
Read More

Abiomed's Impella(R) Technology Showcased at TCT 2012 With Over 25 Scheduled Presentations in the Scientific Sessions

October 15, 2012
Read More

Abiomed Second Quarter Fiscal 2013 Earnings and Conference Call Notification

October 11, 2012
Read More

Medical Technology Veterans Program Kicks Off at AdvaMed2012 in Boston

October 01, 2012
Read More

Abiomed to Present at Credit Suisse 3rd Annual Small and Mid Cap Conference

September 12, 2012
Read More

Abiomed to Present at UBS Global Life Sciences Conference

September 11, 2012
Read More

Abiomed Receives FDA 510(k) Clearance for New, Higher Flow Impella Percutaneous Heart Pump, With Peak Flows of 4L/min

September 10, 2012
Read More

Abiomed to Present at Morgan Stanley 2012 Global Healthcare Conference

September 06, 2012
Read More

Abiomed Announces Publication of PROTECT II Study in Circulation: Journal of the American Heart Association

September 04, 2012
Read More

New Category I CPT Codes for Impella Announced by American Medical Association

September 04, 2012
Read More

Abiomed Announces Record Revenue of $38.8 Million, Up 42% and Worldwide Impella Revenue Growth of 56%

August 02, 2012
Read More

Abiomed First Quarter Fiscal 2013 Earnings and Conference Call Notification

July 12, 2012
Read More

Abiomed Receives Health Canada Approval for Impella cVAD

June 14, 2012
Read More

Abiomed to Present at the Wells Fargo Securities Research and Economics 2012 Healthcare Conference

June 13, 2012
Read More

Abiomed to Present at Goldman Sachs 33rd Annual Global Healthcare Conference

May 31, 2012
Read More

Abiomed to Present at Jefferies 2012 Global Healthcare Conference

May 29, 2012
Read More

Abiomed Announces Record Fourth Quarter Revenue of $37.3 Million, Up 31% and Achieves Profitability for Full Fiscal Year

May 16, 2012
Read More

Abiomed to Present at Bank of America Merrill Lynch 2012 Health Care Conference

May 10, 2012
Read More

Abiomed Fourth Quarter and Full Fiscal Year 2012 Earnings and Conference Call Notification

May 08, 2012
Read More

Abiomed Announces Participation in Three Upcoming Physician Society Meetings: SCAI, HRS, & EuroPCR

May 08, 2012
Read More

Abiomed to Present at Deutsche Bank 37Th Annual Healthcare Conference

May 01, 2012
Read More

Abiomed Receives CE Mark for Impella cVAD

April 12, 2012
Read More

Abiomed Announces First Patient Supported with Impella cVAD

April 03, 2012
Read More
Page:
1
2
...
31
Next Last